An application of agent-based simulation to the management of hospital-acquired infection
暂无分享,去创建一个
Ruth Davies | Yang Meng | Katherine Hardy | Peter Hawkey | R. Davies | P. Hawkey | K. Hardy | Yang Meng
[1] M. Lipsitch,et al. The analysis of hospital infection data using hidden Markov models. , 2004, Biostatistics.
[2] J. Robotham,et al. Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA) , 2006, Epidemiology and Infection.
[3] Thomas W. Lucas,et al. Exploring the world of agent-based simulations: simple models, complex analyses , 2002, Proceedings of the Winter Simulation Conference.
[4] E Massad,et al. Modeling and simulating the evolution of resistance against antibiotics. , 1993, International journal of bio-medical computing.
[5] Charles M. Macal,et al. Managing Business Complexity: Discovering Strategic Solutions with Agent-Based Modeling and Simulation , 2007 .
[6] B. Cooper,et al. Preliminary analysis of the transmission dynamics of nosocomial infections: stochastic and management effects. , 1999, The Journal of hospital infection.
[7] Sheldon Howard Jacobson,et al. Application of discrete-event simulation in health care clinics: A survey , 1999, J. Oper. Res. Soc..
[8] R Tiruvoipati,et al. Efficacy of exogenous surfactant in adult patients with acute respiratory failure , 2006, Critical Care.
[9] S. Chick,et al. A taxonomy of model structures for economic evaluation of health technologies. , 2006, Health economics.
[10] Stephan Harbarth,et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study , 2006, Critical care.
[11] Barbara Messing,et al. An Introduction to MultiAgent Systems , 2002, Künstliche Intell..
[12] Michael J. North,et al. Tutorial on Agent-Based Modeling and Simulation PART 2: How to Model with Agents , 2006, Proceedings of the 2006 Winter Simulation Conference.
[13] A. Reid,et al. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol. , 2007, The Journal of hospital infection.
[14] R. Anderson,et al. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[15] O. Diekmann,et al. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] A J Valleron,et al. A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. , 1997, Computers and biomedical research, an international journal.
[17] Michael Wooldridge,et al. Introduction to multiagent systems , 2001 .
[18] Stephan Harbarth,et al. Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.
[19] James S Koopman,et al. Stochastic effects on endemic infection levels of disseminating versus local contacts. , 2002, Mathematical biosciences.
[20] A. Pettitt,et al. Use of Stochastic Epidemic Modeling to Quantify Transmission Rates of Colonization With Methicillin-Resistant Staphylococcus Aureus in an Intensive Care Unit , 2005, Infection Control & Hospital Epidemiology.
[21] R. Cunningham,et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. , 2007, The Journal of hospital infection.
[22] Christos Vasilakis,et al. Modelling nationwide hospital length of stay: opening the black box , 2005, J. Oper. Res. Soc..
[23] Charles M. Macal,et al. Managing Business Complexity: Discovering Strategic Solutions with Agent-Based Modeling and Simulation , 2007 .
[24] Eric Bonabeau,et al. Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] Ruth Davies,et al. A study of the efficacy and cost-effectiveness of MRSA screening and monitoring on surgical wards using a new, rapid molecular test (EMMS) , 2007, BMC Health Services Research.
[26] D. Austin,et al. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. , 2002, The Journal of infectious diseases.
[27] Sally Blower,et al. Modelling infectious diseases in humans and animals , 2008 .
[28] M. Loeb,et al. Modeling Transmission of Methicillin-Resistant Staphylococcus Aureus Among Patients Admitted to a Hospital , 2005, Infection Control & Hospital Epidemiology.
[29] R Davies,et al. Modelling patient flows and resource provision in health systems , 1994 .
[30] B. Cooper,et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Pettitt,et al. A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions. , 2007, Journal of theoretical biology.
[32] L Morrison,et al. Does MRSA affect patient outcomes in the elderly? A retrospective pilot study. , 2000, The Journal of hospital infection.
[33] M. Keeling,et al. Modeling Infectious Diseases in Humans and Animals , 2007 .
[34] R Raine,et al. Controlling Communicable Disease , 2005 .
[35] Feng Yu,et al. A Hybrid Epidemic Model: Combining The Advantages Of Agent-Based And Equation-Based Approaches , 2007, 2007 Winter Simulation Conference.
[36] S. Cosgrove,et al. The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.
[37] Ruth Davies,et al. Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease , 2008, J. Oper. Res. Soc..
[38] Sylvie Chevret,et al. Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. , 1997 .
[39] J. Hotchkiss,et al. An agent-based and spatially explicit model of pathogen dissemination in the intensive care unit* , 2005, Critical care medicine.